Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
PLoS Negl Trop Dis. 2011 Sep;5(9):e1260. doi: 10.1371/journal.pntd.0001260. Epub 2011 Sep 20.

Resolution of praziquantel.

Author information

  • 1School of Chemistry, The University of Sydney, Sydney, New South Wales, Australia.

Abstract

BACKGROUND:

Praziquantel remains the drug of choice for the worldwide treatment and control of schistosomiasis. The drug is synthesized and administered as a racemate. Use of the pure active enantiomer would be desirable since the inactive enantiomer is associated with side effects and is responsible for the extremely bitter taste of the pill.

METHODOLOGY/PRINCIPAL FINDINGS:

We have identified two resolution approaches toward the production of praziquantel as a single enantiomer. One approach starts with commercially available praziquantel and involves a hydrolysis to an intermediate amine, which is resolved with a derivative of tartaric acid. This method was discovered through an open collaboration on the internet. The second method, identified by a contract research organisation, employs a different intermediate that may be resolved with tartaric acid itself.

CONCLUSIONS/SIGNIFICANCE:

Both resolution procedures identified show promise for the large-scale, economically viable production of praziquantel as a single enantiomer for a low price. Additionally, they may be employed by laboratories for the production of smaller amounts of enantiopure drug for research purposes that should be useful in, for example, elucidation of the drug's mechanism of action.

PMID:
21949890
[PubMed - indexed for MEDLINE]
PMCID:
PMC3176743
Free PMC Article

Images from this publication.See all images (2)Free text

Figure 1
Figure 2
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Public Library of Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk